ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (ALNY)

235.82
-2.15
( -0.90% )
Updated: 13:23:09

Alnylam Pharmaceuticals Inc Financial Summary

The current ALNY market cap is 30.42B. The company's latest EPS is USD -3.4132 and P/E is -69.02.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 750.53M439.72M494.33M659.83M500.92M
Operating Income 213.87M-116.4M-43.44M48.61M-76.91M
Net Income 147.75M-137.87M-65.94M-16.89M-111.57M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 219.75M492.85M844.29M1.04B1.83B
Operating Income -939.43M-828.44M-708.65M-785.07M-282.18M
Net Income -886.12M-858.28M-852.82M-1.13B-440.24M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 3.84B3.83B3.82B4.01B4.21B
Total Liabilities 4B4.05B4.04B4.01B4.17B
Total Equity -165.87M-220.64M-219.27M-3.07M32.35M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 2.4B3.41B3.64B3.55B3.83B
Total Liabilities 956.44M2.39B3.06B3.7B4.05B
Total Equity 1.44B1.02B588.2M-158.22M-220.64M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 133.95M104.16M-81.52M42.64M86.35M
Investing -95.69M-336.35M-67.62M-33.68M-63.93M
Financing 132.9M172.13M28.91M160.41M263.16M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -278.43M-614.96M-641.69M-541.27M104.16M
Investing -417.68M-435.52M-273.3M169.35M-336.35M
Financing 823.18M994.98M1.25B425.75M172.13M
Market Cap 30.42B
Price to Earnings Ratio -69.02
Price to Sales Ratio 16.62
Price to Cash Ratio 37.39
Price to Book Ratio -137.72
Dividend Yield -

Share Statistics

Shares Outstanding 128.98M
Average Volume (1 week) 417.1k
Average Volume (1 Month) 591.67k
52 Week Change 24.19%
52 Week High 304.39
52 Week Low 141.975
Spread (Intraday) 0.32 (0.14%)

Company Info

Company Name Alnylam Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.alnylam.com
Industry pharmaceutical preparations (2834)